This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Soliton, Inc.(NasdaqCM:SOLY) dropped from S&P TMI Index CI
Soliton, Inc.(NasdaqCM:SOLY) dropped from NASDAQ Composite Index CI
Allergan plc completed the acquisition of Soliton, Inc. for approximately $570 million. CI
Soliton Up 12% as Nasdaq Alert Says Sale to AbbVie Is Scheduled to Close Thursday DJ
Soliton, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Soliton, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Soliton : AbbVie, Soliton Providing FTC Extra Time to Review Proposed Deal MT
SOLITON : Roth Capital Downgrades Soliton to Neutral From Buy MT
Soliton, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
SOLITON : Cantor Fitzgerald Downgrades Soliton to Neutral from Overweight, Adjusts Price Target to $22.60 from $25 MT
SOLITON : Maxim Group Downgrades Soliton to Hold From Buy MT
Sector Update: Health Care Stocks Hanging On For Modest Rise MT
Sector Update: Health Care Stocks Extending Monday Gains, Overcoming Biotech Weakness MT
Sector Update: Health Care MT
AbbVie's Allergan Aesthetics to Buy Soliton DJ
AbbVie : Allergan Aesthetics to Acquire Soliton for $22.60 per Share MT
Allergan plc entered into a definitive agreement to acquire Soliton, Inc. for approximately $510 million. CI
Soliton, Inc. Announces Introducing RESONIC™ CI
Soliton, Inc. Receives FDA Clearance of Special 510(K) CI
Soliton : 501k Application for RESONIC Device Accepted by FDA MT
Soliton, Inc. Provides Special 510(K) and Commercialization Update CI
Soliton : Initiates Second Animal Study for Potential Liver Fibrosis Treatment MT
Soliton Announces Initiation of Second Animal Study for Potential RAP Treatment of Liver Fibrosis CI
Soliton, Inc. Reports Earnings Results for the Fourth Quarter and Year Ended December 31, 2020 CI
Soliton Selects RESONIC™ As Brand Name for FDA-Cleared Rapid Acoustic Pulse Device CI
Chart Soliton, Inc.
More charts
Soliton Inc is a medical technology company. The Company is focused on developing and commercializing products utilizing its designed acoustic shockwave technology platform referred to as Rapid Acoustic Pulse (RAP). It develops products for the removal of tattoos and the reduction of cellulite. The RAP device in coordination with the pulsed laser removes ink pigment from the macrophages. Its RAP device uses pulses of designed acoustic shockwaves to disrupt cellular structures in the dermal and subdermal tissue. It's designed shockwave allows it to target the stiffness between cellular structures and generate an effect that represents a platform technology in tattoo removal, cellulite treatment, fibrotic scar treatment and other indications. Its technology allows the disruption of targeted structures within the skin with minimal discomfort and without additional treatment-related downtime for tattoo removal or any downtime for cellulite treatment.
More about the company
  1. Stock Market
  2. Equities
  3. SOLY Stock
  4. News Soliton, Inc.
  5. Soliton : Names Brad Hauser Chief Executive; Shares Rise